1. GLP-1 RAs linked to 27% increased GERD risk in T2D patients. 2. The study analyzed data from 24,708 GLP-1 RA users. 3. Incidence of GERD was 3.1 per 100 patients in the GLP-1 RA group. 4. GERD-related complications include Barrett esophagus, with higher rates in GLP-1 RA users. 5. Higher risks observed in smokers and obese patients.
Source: Annals of Internal Medicine
